Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.

<h4>Background</h4>COVID-19 may present with a variety of clinical syndromes, however, the upper airway and the lower respiratory tract are the principle sites of infection. Previous work on respiratory viral infections demonstrated that airway inflammation results in the release of vola...

Full description

Bibliographic Details
Main Authors: Matthew C Exline, Milutin Stanacevic, Andrew S Bowman, Pelagia-Irene Gouma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0257644
_version_ 1818721764578951168
author Matthew C Exline
Milutin Stanacevic
Andrew S Bowman
Pelagia-Irene Gouma
author_facet Matthew C Exline
Milutin Stanacevic
Andrew S Bowman
Pelagia-Irene Gouma
author_sort Matthew C Exline
collection DOAJ
description <h4>Background</h4>COVID-19 may present with a variety of clinical syndromes, however, the upper airway and the lower respiratory tract are the principle sites of infection. Previous work on respiratory viral infections demonstrated that airway inflammation results in the release of volatile organic compounds as well as nitric oxide. The detection of these gases from patients' exhaled breath offers a novel potential diagnostic target for COVID-19 that would offer real-time screening of patients for COVID-19 infection.<h4>Methods and findings</h4>We present here a breath tester utilizing a catalytically active material, which allows for the temporal manifestation of the gaseous biomarkers' interactions with the sensor, thus giving a distinct breath print of the disease. A total of 46 Intensive Care Unit (ICU) patients on mechanical ventilation participated in the study, 23 with active COVID-19 respiratory infection and 23 non-COVID-19 controls. Exhaled breath bags were collected on ICU days 1, 3, 7, and 10 or until liberation from mechanical ventilation. The breathalyzer detected high exhaled nitric oxide (NO) concentration with a distinctive pattern for patients with active COVID-19 pneumonia. The COVID-19 "breath print" has the pattern of the small Greek letter omega (). The "breath print" identified patients with COVID-19 pneumonia with 88% accuracy upon their admission to the ICU. Furthermore, the sensitivity index of the breath print (which scales with the concentration of the key biomarker ammonia) appears to correlate with duration of COVID-19 infection.<h4>Conclusions</h4>The implication of this breath tester technology for the rapid screening for COVID-19 and potentially detection of other infectious diseases in the future.
first_indexed 2024-12-17T20:43:55Z
format Article
id doaj.art-a77c431d6ddd435698467895be10f67a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T20:43:55Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a77c431d6ddd435698467895be10f67a2022-12-21T21:33:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-011610e025764410.1371/journal.pone.0257644Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.Matthew C ExlineMilutin StanacevicAndrew S BowmanPelagia-Irene Gouma<h4>Background</h4>COVID-19 may present with a variety of clinical syndromes, however, the upper airway and the lower respiratory tract are the principle sites of infection. Previous work on respiratory viral infections demonstrated that airway inflammation results in the release of volatile organic compounds as well as nitric oxide. The detection of these gases from patients' exhaled breath offers a novel potential diagnostic target for COVID-19 that would offer real-time screening of patients for COVID-19 infection.<h4>Methods and findings</h4>We present here a breath tester utilizing a catalytically active material, which allows for the temporal manifestation of the gaseous biomarkers' interactions with the sensor, thus giving a distinct breath print of the disease. A total of 46 Intensive Care Unit (ICU) patients on mechanical ventilation participated in the study, 23 with active COVID-19 respiratory infection and 23 non-COVID-19 controls. Exhaled breath bags were collected on ICU days 1, 3, 7, and 10 or until liberation from mechanical ventilation. The breathalyzer detected high exhaled nitric oxide (NO) concentration with a distinctive pattern for patients with active COVID-19 pneumonia. The COVID-19 "breath print" has the pattern of the small Greek letter omega (). The "breath print" identified patients with COVID-19 pneumonia with 88% accuracy upon their admission to the ICU. Furthermore, the sensitivity index of the breath print (which scales with the concentration of the key biomarker ammonia) appears to correlate with duration of COVID-19 infection.<h4>Conclusions</h4>The implication of this breath tester technology for the rapid screening for COVID-19 and potentially detection of other infectious diseases in the future.https://doi.org/10.1371/journal.pone.0257644
spellingShingle Matthew C Exline
Milutin Stanacevic
Andrew S Bowman
Pelagia-Irene Gouma
Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.
PLoS ONE
title Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.
title_full Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.
title_fullStr Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.
title_full_unstemmed Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.
title_short Exhaled nitric oxide detection for diagnosis of COVID-19 in critically ill patients.
title_sort exhaled nitric oxide detection for diagnosis of covid 19 in critically ill patients
url https://doi.org/10.1371/journal.pone.0257644
work_keys_str_mv AT matthewcexline exhalednitricoxidedetectionfordiagnosisofcovid19incriticallyillpatients
AT milutinstanacevic exhalednitricoxidedetectionfordiagnosisofcovid19incriticallyillpatients
AT andrewsbowman exhalednitricoxidedetectionfordiagnosisofcovid19incriticallyillpatients
AT pelagiairenegouma exhalednitricoxidedetectionfordiagnosisofcovid19incriticallyillpatients